Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia

摘要

Background Eradication rates of standard triple therapy for Helicobacter pylori infections have decreased in recent years due to a worldwide increase in bacterial resistance. Sequential therapy has the advantage of a two-phase treatment regimen and achieves a superior result for H. pylori eradication in peptic ulcer disease. However, no study has yet compared the efficacy of sequential therapy for H. pylori eradication exclusively in inactive duodenal ulcer (iDU) or non-ulcer dyspepsia (NUD). Method We retrospectively recruited 408 patients with endoscopic proven iDU (170 patients) or NUD (238 patients) infected with H. pylori . Patients with iDU were assigned into two groups: iDU triple therapy group, 44 patients treated with 40?mg pantoprazole, 1000?mg amoxicillin and 500?mg clarithromycin, twice daily for 7?days; iDU sequential therapy group, 126 patients treated with 40?mg pantoprazole and 1000?mg amoxicillin, twice daily for the first 5?days, followed by 40?mg pantoprazole, 500?mg clarithromycin and 500?mg tinidazole, twice daily for the next 5?days. All patients with NUD were treated with sequential therapy and assigned as the NUD sequential group. Post-treatment H. pylori status was confirmed by a 13C-urea breath test. Result The eradication rates of intention-to-treat (ITT) and per-protocol (PP) analysis were 77.3?% (95?% CI 64.9–89.7?%) and 85.0?% (95?% CI 73.9–96.1?%) in the iDU triple therapy group and 87.3?% (95?% CI 81.5–93.1?%) and 92.4?% (95?% CI 87.6–97.2?%) in the iDU sequential therapy group. The overall eradication efficacy was superior in the sequential group than in the triple group, both with ITT analysis (83.5?% vs. 77.3?%, P =?0.29) and PP analysis (88.1?% vs. 85.0?%, P?=?0.57). Eradication rates for ITT and PP analysis were 81.5?% (95?% CI 76.6–86.4?%) and 85.8?% (95?% CI 83.5–88.2?%) in the NUD sequential therapy group. Eradication rate was statistically better in the iDU sequential therapy group than the NUD sequential therapy group according to per protocol analysis ( P =?0.04). Eradication rate was not significantly different between the iDU sequential- and iDU triple therapy groups according to protocol analysis ( P =?0.14). Conclusion The sequential regimen has a better eradiation rate in the iDU group than in the NUD group. There is no statistically difference between 10-day sequential therapy and 7-day standard triple in iDU group.